GL1X · GenesisL1 explorer

Research workbench

Crystal structure of rous sarcoma virus protease in complex with inhibitor

Analyse Crystal structure of rous sarcoma virus protease in complex with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1BAI
Type
protein
Length
248 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
O92805
Ligands
0Q4
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProteaseprotein1245% helix, 44% strandO92805

Ligands and binding sites

  • 0Q4 · N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14490.700.81390Q4

Interfaces

1 interface between chains.

  • A–B · 1884 Ų buried · 51 hydrogen bonds · protein-protein

Compared structures

  • 1BAI · Crystal structure of Rous sarcoma virus protease in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.